Axsome Therapeutics Inc. logo

Axsome Therapeutics Inc.

AXSM | NASDAQ
Chart Builder DCF Calculator
$132.57
-$11.86 (-8.21%)
Nov 2, 2026, 2:32 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Cash & Equivalents
322.93M 315.35M 386.19M 200.84M 86.47M 183.88M
Short-Term Investments
n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
27.4M 18.53M 11.03M 14.72M 322.91K 317.38K
Receivables
224.46M 142M 94.82M 37.7M n/a n/a
Inventory
27.94M 15.73M 15.14M 4.32M n/a n/a
Other Current Assets
13.65M 11.98M 8.12M 2.78M n/a n/a
Total Current Assets
588.99M 485.06M 504.26M 245.64M 86.52M 184.02M
Property-Plant & Equipment
20.86M 5.97M 7.62M 1.14M 944.01K 1.79M
Goodwill & Intangibles
52.56M 58.94M 65.33M 69.97M n/a n/a
Total Long-Term Assets
100.82M 83.43M 83.97M 85.83M 1.27M 2.11M
Total Assets
689.81M 568.5M 588.24M 331.48M 87.79M 186.13M
Account Payables
65.54M 72M 40.68M 38.61M 13.15M 13.5M
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
72.98M n/a n/a n/a n/a n/a
Other Current Liabilities
203.28M 36.51M 76.45M 17.18M 4.05M n/a
Total Current Liabilities
378.84M 230.1M 138.85M 96.56M 23.07M 23.44M
Long-Term Debt
140.93M 180.71M 178.07M 94.26M 49.09M 48.32M
Other Long-Term Liabilities
54.36M 91.68M 73.3M 31.1M n/a n/a
Total Long-Term Liabilities
222.67M 281.38M 258.41M 125.36M 49.09M 48.9M
Total Liabilities
601.51M 511.48M 397.26M 221.92M 72.15M 72.34M
Total Debt
241.3M 192.96M 186.37M 94.68M 49.71M 50.12M
Book Value
88.3M 57.02M 190.98M 109.56M 15.63M 113.79M
Book Value Per Share
1.77 1.19 4.20 2.69 0.42 3.06
Common Stock
5K 5K 5K 4K 3.78K 3.74K
Retained Earnings
-1.31B -1.12B -835.57M -596.33M -409.2M -278.8M
Comprehensive Income
n/a n/a n/a n/a n/a n/a
Shareholders Equity
88.3M 57.02M 190.98M 109.56M 15.63M 113.79M
Total Investments
n/a n/a n/a n/a n/a n/a

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.